In addition, it addresses the FDA’s communications With all the applicant, the retention of information that aid the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of the SE report back to a whole new applicant and electronic submission on the SE r